Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Bertagnolio

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
BMJ (Clinical Research Ed.)|September 22, 2012
Improving systems to monitor transmitted HIV drug resistanceSilvia Bertagnolio
AIDS (London, England)|July 30, 2005
WHO approach to track HIV drug resistance emergence and transmission in countries scaling up HIV treatmentSilvia Bertagnolio, Donald Sutherland
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010Neil Parkin, James Bremer, Silvia Bertagnolio
The New England Journal of Medicine|March 6, 2018
HIV Drug ResistanceSilvia Bertagnolio, Michael R Jordan, Meg Doherty
Trends in Microbiology|November 18, 2025
Advancing equity in antimicrobial resistance research and policyZlatina Dobreva, Chad M Centner, Silvia Bertagnolio
Current Opinion in HIV and AIDS|April 27, 2011
Integrated surveillance of HIV care in low-income and middle-income countriesJean-Michel Tassie, Silvia Bertagnolio, Yves Souteyrand
The Lancet. HIV|May 11, 2020
Is increasing pretreatment HIV drug resistance a real menace or minor detail?Seth C Inzaule, Raph L Hamers, Silvia Bertagnolio
The Lancet. Infectious Diseases|August 2, 2016
Tenofovir resistance and first-line antiretroviral therapyNathan Ford, Marco Vitoria, Meg Doherty, et al.
Current Opinion in HIV and AIDS|June 28, 2022
Epidemiology of HIV drug resistance in low- and middle-income countries and WHO global strategy to monitor its emergenceSilvia Bertagnolio, Michael R Jordan, Amalia Giron, et al.
AIDS (London, England)|August 24, 2004
HIV drug resistance surveillance: summary of an April 2003 WHO consultationStefano Lazzari, Annapaola de Felici, Howard Sobel, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
BMJ (Clinical Research Ed.)|September 22, 2012
Improving systems to monitor transmitted HIV drug resistanceSilvia Bertagnolio
AIDS (London, England)|July 30, 2005
WHO approach to track HIV drug resistance emergence and transmission in countries scaling up HIV treatmentSilvia Bertagnolio, Donald Sutherland
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010Neil Parkin, James Bremer, Silvia Bertagnolio
The New England Journal of Medicine|March 6, 2018
HIV Drug ResistanceSilvia Bertagnolio, Michael R Jordan, Meg Doherty
Trends in Microbiology|November 18, 2025
Advancing equity in antimicrobial resistance research and policyZlatina Dobreva, Chad M Centner, Silvia Bertagnolio
Current Opinion in HIV and AIDS|April 27, 2011
Integrated surveillance of HIV care in low-income and middle-income countriesJean-Michel Tassie, Silvia Bertagnolio, Yves Souteyrand
The Lancet. HIV|May 11, 2020
Is increasing pretreatment HIV drug resistance a real menace or minor detail?Seth C Inzaule, Raph L Hamers, Silvia Bertagnolio
The Lancet. Infectious Diseases|August 2, 2016
Tenofovir resistance and first-line antiretroviral therapyNathan Ford, Marco Vitoria, Meg Doherty, et al.
Current Opinion in HIV and AIDS|June 28, 2022
Epidemiology of HIV drug resistance in low- and middle-income countries and WHO global strategy to monitor its emergenceSilvia Bertagnolio, Michael R Jordan, Amalia Giron, et al.
AIDS (London, England)|August 24, 2004
HIV drug resistance surveillance: summary of an April 2003 WHO consultationStefano Lazzari, Annapaola de Felici, Howard Sobel, et al.
Pageof 12